Biotech stocks are surging. How investors can play the new drug innovation boom

The Quick Take
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to CNBC.



